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Prostaglandins-A Promising Future 
by 
J eaneyl Hazlett· 
Prostaglandins were discovered almost 
forty years ago, but their elucidation phys-
iologically is in its infancy today. It was 
only in 1957 that the first prostaglandin, 
PGF1-alpha, was crystallized from sheep 
seminal vesicles. By 1966, all of the 
known fourteen natural prostaglandins 
had been synthesized from commercially 
available materials. 1 Research data has 
been compiled at a remarkable rate dur-
ing the last three to five years. 
Prostaglandins are unsaturated 20-
carbon fatty acids whose varying structural 
differences determine their action on 
smooth muscle and blood pressure. There 
are four main types labeled A, B, E, and 
F; and E and F types are considered pri-
mary as they are produced directly from 
fatty acid precursors in cell microsomes. 
PGAl> PGA2 , PGEl> and PGE2-alpha are 
currently being investigated the most be-
cause of their pharmacological activity.l 
PGF 2-alpha and PGE2 are being used clin-
ically in Europe and are under test in the 
United States. 
Exactly how all prostaglandins function 
in the body is not known, but they can be 
found in all tissues of the body. Possibly 
they are related to the cyclic AMP path-
ways (cyclic adenosine 3,5'-monophos-
ph ate) affecting the amount formed, act-
ing as a hormone, or a relay for a hormone. 
Although phYSiologically prostaglandins 
have not been explained, many of their 
pharmacological effects have been investi-
gated in both man and animals, especially 
their action on smooth muscle.2 
PGF2-alpha is produced by the uterus 
and is believed to be a luteolytic hormone 
which terminates the life of the corpus 
luteum in ovine, bovine, porcine and 
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equine species.2 In the ovine, bovine, and 
porcine the uterine luteolysin passes to the 
ovary thm a local pathway. Likewise, 
when intrauterine PGF2-alpha is used it 
must be placed in the uterine horn ip'Sil-
lateral to the ovary containing the active 
corpus luteum. Allen and Rowson report~ 
that in cattle when PGF 2-alpha is infused 
into the uterus on two successive days be-
tween day 5-16 of the cycle (day O-ovula-
tion), it induces estrus three days later. 
Tervit, Rowson, and Brand report equal 
success with PGF 2-alpha analogue (ICI-
79939), by increasing the I.U. dose and 
giving it I.M., making it more practical to 
use.4 
Due to their luteolytic activity as report-
ed by E. K. Inskeep,2 prostaglandins can 
be used effectively as abortifacients and 
parturition inducers in cattle and pigs. 
Studies in man have shown advantages 
over the use of oxytocin which can pro-
duce tetanic contraction. POSSibly in the 
future prostaglandins could be used to 
terminate a near parturition calf of super-
sire breeding to prevent dystocia problems 
commonly seen in some Holsteins and 
exotic breeds. 
The mare is a different story. A uni-
lateral hysterectomy prolongs the life of 
the corpus luteum in some mares, but not 
in others. The ratio in which mainten-
ance occurs is similar with no relationship 
to whether the CL is contralateral or ipsil-
lateral to the remaining horn, suggesting 
that the luteolysin reaches the ovaries thru 
the blood vascular system. 
The estrous cycle of the mare is twenty-
two days with a variable estrus of three 
to ten days. Ovulation occurs twenty-four 
to forty-eight hours before the end of 
estrus. Allen and Rowson have shown that 
using a potent analogue of PGF2-alpha 
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(ICI79939)3.4 they could shorten the dies-
tral period of mares. An I. U. or I. M. in-
jection of 230 ugm given during the fourth 
to thirteenth day of diestrus for two days 
brought the mares into estrus in three 
days, and ovulation occurred in seven to 
twelve days peaking at ten days. If given 
before three days old, the CL is not suscep-
tible. 
There are many clinical possibilities for 
the use of prostaglandins in the mare. 
Using prostaglandins, one could control 
and shorten the cycle of the mare by de-
creasing the time spent in diestrus. They 
could be of particular importance on the 
breeding farm where many mares are 
booked to one stallion so that the estrus 
periods could be planned to prevent con-
current estrus periods. Where A. I. is prac-
ticed prostaglandins would prove invalu-
able. In Thoroughbred mares whose breed-
ing season is restricted and A. I. not allow-
ed by the breed registration authorities 
prostaglandins could shorten estral cycles 
from 22 to 14 days,:! thus increasing the 
number of possible cycles per season. As 
a final touch, they provide a means of 
treating the "problem mare" with a per-
sistant CL which prevents normal cycling. 
This category could include early abortion, 
resorption, barren or lactating mares. 
Although the main emphasis in re-
search has been on reproduction, prosta-
glandins show promise in various other 
areas of research relating to man and 
animals. 1 
ULCERS-Certain prostaglandins decrease 
gastric acid secretion in the dog, pos-
sibly relating to peptic ulcers in man. 
HYPERTENSION - The A and E groups 
decrease blood pressure by dilating 
peripheral vessels, while PGF types 
increase blood pressure. 
KIDNEY DISEASE-PGF1 , PGF2 , and 
PGA, effect the kidney causing an in-
creased renal blood flow, urine vol-
ume and sodium excretion. Possibly 
congenital heart disease and kidney 
failure are related to a lack of natural 
PGF 2 production. 
THROMBI-PGE1 inhibits thombus forma-
tion while PGF 2 stimulates it. 
RESPIRATORY DISEASE - PGE1 and 
PGF2 relax the smooth muscle of 
bronchioles in animals and man. It 
has been shown to be a more potent 
bronchiodilator than isoproterenal. 
Prostaglandins have also been impli-
cated as causes of various pathological 
conditions, including glaucoma, tumors 
and inflammation. The research informa-
tion increases daily and the day is near 
that we will have prostaglandins as thera-
peutic' agents. Only time will tell if they 
will live up to their expectations. 
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Drug Interactions 
by 
Gary A. Eckhoff. D.V.M., M.S.* 
Rapid advances in research in basic 
pharmacology and the productivity of the 
pharmaceutical industry have resulted in 
the introduction of many new drugs for 
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the veterinary profession. The availability 
of large numbers of drugs has stimulated 
their concomitant use with the hope that 
maximum therapeutic effectiveness will 
be achieved. Indeed modern therapeutics 
in veterinary medicine often necessitates 
the simultaneous administration of several 
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